Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machover, D.
Right arrow Articles by Hoffman, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machover, D.
Right arrow Articles by Hoffman, R. M.
[Cancer Research 62, 4685-4689, August 15, 2002]
© 2002 American Association for Cancer Research


Experimental Therapeutics

Treatment of Cancer Cells with Methioninase Produces DNA Hypomethylation and Increases DNA Synthesis1

David Machover2, Jacqueline Zittoun, Raphaël Saffroy, Philippe Broët, Stéphane Giraudier, Thierry Magnaldo, Emma Goldschmidt, Brigitte Debuire, Mireille Orrico, Yuying Tan, Zohar Mishal, Odile Chevallier, Carole Tonetti, Hélène Jouault, Ayhan Ulusakarya, Marie-Laure Tanguy, Gérard Metzger and Robert M. Hoffman

Hematology and Oncology Department and Institut du Cancer et d’Immunogénétique, Hospital Paul-Brousse, 94804 Villejuif, France [D. M., E. G., A. U., G. M.]; Service of Biological Hematology, Hospital Henri-Mondor, 94000 Créteil, France [J. Z., S. G., M. O., C. T., H. J.]; Laboratory of Biochemistry and Molecular Biology [R. S., B. D.], Biostatistics and Public Health Unit [P. B., M-L. T.], INSERM U472, Hospital Paul-Brousse, 94804 Villejuif, France; Cancer and Genetic Instability Unit, CNRS UPR 2169, Institute André-Lwoff, 94800 Villejuif, France [T. M., O. C.]; AntiCancer Inc., San Diego, California 92111 [Y. T., R. M. H.]; and Cytometry Unit, Institute André-Lwoff, 94800 Villejuif, France [Z. M.]

Methionine depletion in the human cell line CCRF-CEM through the action of recombinant methioninase (rMETase), a methionine-cleaving enzyme, was previously demonstrated to produce a strong cytotoxic synergistic effect with fluorouracil (FUra) throughout a broad range of concentrations of FUra and rMETase, including subcytotoxic levels of rMETase. Potentiation was associated with a decrease in free thymidylate synthase from preexisting levels. To further investigate the action of rMETase on CCRF-CEM cells, in the present study we explored the effects of rMETase as a single agent on DNA methylation levels and DNA synthesis, which may be changed as a result of deprivation of methionine. Cells treated with rMETase under subcytotoxic conditions contained significantly lower levels of genomic methylated DNA than did control cells, as demonstrated by incorporation of the methyl radical of [methyl-3H]S-adenosylmethionine in DNA and by use of methylation-sensitive arbitrarily primed PCR. DNA hypomethylation produced by rMETase was of similar magnitude as that produced with the DNA methyltransferase inhibitor 5-azacytidine. Cells exposed to rMETase synthesized significantly more DNA than did untreated cells. Incorporation of [6-3H]thymidine and [6-3H]2'-deoxyuridine in these cells was augmented over that in control by mean factors of 1.78 and 2.36, respectively. Increased 3H nucleoside incorporation resulted in greater numbers of nuclear grains as demonstrated by autoradiography. The increase in DNA synthesis induced by rMETase is likely to result from enhancement of DNA repair because it was not accompanied by differences in cell cycle phase distribution or in total DNA content as determined by flow cytometry. We hypothesize that potentiation of FUra cytotoxicity by rMETase may result from increased inhibition of thymidylate synthase, together with DNA hypomethylation and enhanced DNA repair that could be involved in cell responses to drug-induced damage.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. Saffroy, P. Pham, F. Chiappini, M. Gross-Goupil, L. Castera, D. Azoulay, A. Barrier, D. Samuel, B. Debuire, and A. Lemoine
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis
Carcinogenesis, August 1, 2004; 25(8): 1443 - 1448.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.